Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
JAACAP Open|September 9, 2025
Systematic Review and Meta-Analysis: Prevalence of Neurodevelopmental Disorders Among Indigenous ChildrenStuart C Lau, Natalie M Czuczman, Liz Dennett, et al.British Journal of Haematology|July 6, 2013
The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphomaJuan J Gu, Francisco J Hernandez-Ilizaliturri, Gregory P Kaufman, et al.Anti-Cancer Drugs|September 3, 2013
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical modelsJuan J Gu, Francisco J Hernandez-Ilizaliturri, Cory Mavis, et al.Blood|December 18, 2015
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivoNatalie M Czuczman, Matthew J Barth, Juan Gu, et al.Pageof 1